Is psychosis common in dialysis patients, especially when they are on antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psychosis in Dialysis Patients and Antibiotic-Associated Risk

While depression and anxiety are extremely common in dialysis patients (affecting 25-50% of this population), frank psychosis is not a typical manifestation of dialysis itself, but antibiotics can independently trigger acute psychotic episodes in vulnerable patients, including those on dialysis. 1, 2, 3

Baseline Psychiatric Burden in Dialysis Patients

The dialysis population carries a substantial psychiatric burden, but this typically manifests as mood and anxiety disorders rather than psychosis:

  • Depression affects 25-50% of dialysis patients when using self-reported measures, with approximately 25% meeting criteria for clinical depression using validated instruments like the Beck Depression Inventory 1

  • Anxiety is present in approximately 45% of dialysis patients, with mean anxiety scores significantly higher than normal subjects 1

  • Hostility and anger are also documented in this population, contributing to overall psychological distress 1

These psychological factors arise from multiple mechanisms including uremia itself, inadequate dialysis, anemia, physiological changes (hypercortisolemia, altered catecholamines, impaired platelet function), and the psychosocial burden of chronic illness 1, 4

Antibiotic-Associated Psychosis: A Real Risk

Psychosis specifically triggered by antibiotics is well-documented and represents a distinct clinical entity:

  • Multiple antibiotic classes can cause acute psychosis, including fluoroquinolones, penicillins, macrolides, cephalosporins, trimethoprim-sulfamethoxazole, and doxycycline, with odds ratios ranging from 1.67 to 9.48 compared to minocycline 2, 3

  • The temporal relationship is typically rapid: onset occurs within 1 week of antibiotic initiation, and resolution occurs within 1 week of discontinuation in most cases 3

  • Approximately 60% of reported cases show a "highly suggestive" causal relationship, including documented cases of psychosis recurrence upon rechallenge with the same antibiotic 3

  • Many cases resolve without antipsychotic treatment after antibiotic discontinuation, supporting a direct drug effect 3

Special Vulnerability in Dialysis Patients

Dialysis patients face compounded risk for antibiotic-associated psychosis:

  • Altered pharmacokinetics: Impaired renal clearance leads to drug accumulation, and hemodialysis affects volume of distribution and blood levels of medications in complex ways 5

  • Polypharmacy and drug interactions: Hospitalized dialysis patients are particularly vulnerable due to acute illness affecting drug metabolism and multiple concomitant CNS-active medications 6

  • Pre-existing psychiatric conditions: Men with psychiatric history are significantly more likely to develop antibiotic-associated psychosis 3

  • Historical precedent: Even phenothiazines (antipsychotics) themselves have caused toxic psychosis in dialysis patients due to accumulation, highlighting the vulnerability of this population to CNS drug effects 7

Clinical Approach

When evaluating behavioral changes in dialysis patients on antibiotics:

  1. First, optimize dialysis adequacy and anemia control, as inadequate dialysis and severe anemia (hemoglobin <8.8 g/dL) directly contribute to behavioral changes 1, 4

  2. Conduct thorough medication reconciliation to identify the specific antibiotic and timing of symptom onset relative to antibiotic initiation 6, 3

  3. If psychosis onset correlates with antibiotic use (within days of starting), strongly consider antibiotic-induced psychosis and discontinue or switch the offending agent if clinically feasible 3

  4. Distinguish from depression/anxiety: True psychosis (hallucinations, delusions, disorganized behavior) differs from the more common depression and anxiety seen in dialysis patients 1, 8

  5. If antipsychotic treatment is required, aripiprazole has demonstrated safety and efficacy in dialysis patients, including as a long-acting injection, based on favorable pharmacokinetic properties 8, 5

Critical Pitfalls to Avoid

  • Do not assume all behavioral changes are "just depression" in dialysis patients—consider antibiotic-induced psychosis when temporal relationship exists 2, 3

  • Do not continue the offending antibiotic if psychosis is suspected—many cases resolve spontaneously after discontinuation 3

  • Avoid phenothiazines in dialysis patients due to historical reports of toxic psychosis from drug accumulation 7

  • Regular medication review by clinical pharmacists can reduce hospitalizations and identify problematic drug interactions in dialysis patients 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Psychosis as an adverse effect of antibiotics.

Brain, behavior, & immunity - health, 2020

Guideline

Management of Thrombocytopenia and Behavioral Changes in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antipsychotics and hemodialysis: A systematic review.

Asian journal of psychiatry, 2021

Guideline

Pregabalin Use in Hospitalized Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical Reasoning in the Use of Long-acting Aripiprazole in Psychosis in Bilateral Nephrectomy on Hemodialysis.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.